InvestorsHub Logo
Followers 22
Posts 713
Boards Moderated 0
Alias Born 02/18/2014

Re: gr8db8 post# 43

Wednesday, 03/25/2015 10:49:04 PM

Wednesday, March 25, 2015 10:49:04 PM

Post# of 2099
One major risk is if VBL cannot begin Phase III on VB-111. They have abandoned one drug in Phase II already because it was no longer worth pursuing. That was VB-201.

But with the recent success of VB-111, it seems they'll move forward with their plan to begin Phase III mid-2015.
Volume:
Day Range:
Bid:
Ask:
Last Trade Time:
Total Trades:
  • 1D
  • 1M
  • 3M
  • 6M
  • 1Y
  • 5Y
Recent VBLT News